Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation

被引：55

作者：

Rosen, HR

Benner, KG

Flora, KD

Rabkin, JM

Orloff, SL

Olyaei, A

Chou, SW

机构：

[1] OREGON HLTH SCI UNIV,DEPT SURG,PORTLAND,OR 97207

[2] VET ADM MED CTR,PORTLAND 97207,DORSET,ENGLAND

[3] OREGON HLTH SCI UNIV,DEPT LIVER TRANSPLANTAT PROGRAM,PORTLAND,OR 97207

来源：

TRANSPLANTATION | 1997年 / 63卷 / 03期

关键词：

D O I：

10.1097/00007890-199702150-00026

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：476 / 478

页数：3

共 9 条

[1] GANCICLOVIR SUSCEPTIBILITIES OF CYTOMEGALOVIRUS (CMV) ISOLATES FROM SOLID-ORGAN TRANSPLANT RECIPIENTS WITH CMV VIREMIA AFTER ANTIVIRAL PROPHYLAXIS
BOIVIN, G
ERICE, A
CRANE, DD
DUNN, DL
BALFOUR, HH
[J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) : 332 - 335
[2] FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES
CHOU, SW
GUENTZEL, S
MICHELS, KR
MINER, RC
DREW, WL
[J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) : 239 - 242
[3] ANALYSIS OF THE UL97 PHOSPHOTRANSFERASE CODING SEQUENCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES AND IDENTIFICATION OF MUTATIONS CONFERRING GANCICLOVIR RESISTANCE
CHOU, SW
ERICE, A
JORDAN, MC
VERCELLOTTI, GM
MICHELS, KR
TALARICO, CL
STANAT, SC
BIRON, KK
[J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 576 - 583
[4] FAILURE OF HIGH-DOSE ORAL ACYCLOVIR TO SUPPRESS CMV VIRURIA OR INDUCE GANCICLOVIR-RESISTANT CMV IN HIV ANTIBODY-POSITIVE PATIENTS
DREW, WL
ANDERSON, R
LANG, W
MINER, RC
DAVIS, G
LALEZARI, J
[J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (03): : 289 - 291
[5] PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION
DREW, WL
MINER, RC
BUSCH, DF
FOLLANSBEE, SE
GULLETT, J
MEHALKO, SG
GORDON, SM
OWEN, WF
MATTHEWS, TR
BUHLES, WC
DEARMOND, B
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) : 716 - 719
[6] PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS
ERICE, A
CHOU, S
BIRON, KK
STANAT, SC
BALFOUR, HH
JORDAN, MC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) : 289 - 293
[7] THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL-TRANSPLANT RECIPIENTS
MCCARTHY, JM
KARIM, MA
KRUEGER, H
KEOWN, PA
[J]. TRANSPLANTATION, 1993, 55 (06) : 1277 - 1282
[8] Cytomegalovirus prophylaxis in solid organ transplant recipients
Patel, R
Snydman, DR
Rubin, RH
Ho, M
Pescovitz, M
Martin, M
Paya, CV
[J]. TRANSPLANTATION, 1996, 61 (09) : 1279 - 1289
[9] RANDOMIZED COMPARISON OF GANCICLOVIR AND HIGH-DOSE ACYCLOVIR FOR LONG-TERM CYTOMEGALOVIRUS PROPHYLAXIS IN LIVER-TRANSPLANT RECIPIENTS
WINSTON, DJ
WIRIN, D
SHAKED, A
BUSUTTIL, RW
[J]. LANCET, 1995, 346 (8967): : 69 - 74

← 1 →